Phenotype, genotype, intelligence & Radiology-X
The launch of a new scientific journal is both an act of optimism and an act of responsibility. It reflects a belief that knowledge is not static, that disciplines evolve, and that new platforms are needed to guide, curate, and accelerate that evolution. Radiology-X emerges at a particularly consequential moment in the journey of medicine—a moment when imaging is no longer merely a diagnostic adjunct but is rapidly becoming one of the central pillars upon which the entire practice of medicine must stand.
For decades, medical progress has been described through advances in therapeutics, surgical techniques, and molecular biology, which continue to be the foundational stones of medicine. Increasingly, we recognize that imaging defines how we see disease, how we classify it, how we measure its trajectory, how we decide the intervention, and how we monitor the outcomes. Imaging has moved from depicting anatomy to revealing function, from identifying pathology to characterizing biology, and from supporting decisions to shaping them. In many ways, imaging has become the language through which modern medicine understands itself.
As we look ahead, it is becoming evident that the future of medicine will rest on three interdependent and mutually reinforcing pillars. The first is phenotyping, driven by ever-advancing imaging technologies. The second is genotyping, enabled by the widespread accessibility of genomic sequencing and genome-wide association studies. The third is analysis, increasingly powered by artificial intelligence (AI), which integrates and interprets vast and complex datasets. Together, these three legs—phenotype, genotype, and intelligent analysis—will define a new architecture of medicine.
Among these, imaging occupies a uniquely central position. It is the most immediate, scalable, and non-invasive means of capturing the phenotype—the observable expression of disease in the living human. While genotyping provides the blueprint, AI offers the interpretive engine, and imaging provides the living map. It allows us to see disease unfold in space and time, to quantify its burden, and to evaluate its response to intervention. It bridges biology and clinical care in a way few other modalities can.
We are already witnessing this transformation. Radiology is no longer confined to identifying lesions or measuring dimensions. It now encompasses radiomics, where quantitative features extracted from images reveal patterns invisible to the human eye; molecular imaging, which visualizes biological processes at the cellular and subcellular levels; and functional imaging, which captures dynamic physiological states. These advances are redefining disease not as a binary presence or absence, but as a spectrum characterized by measurable and reproducible phenotypic signatures.
At the same time, genotyping is undergoing a revolution. The decreasing costs and increasing accessibility of sequencing technologies have enabled the characterization of the genetic underpinnings of disease at an unprecedented scale. Genome-wide association studies are uncovering susceptibility loci, while whole-genome and whole-exome sequencing are identifying mutations that drive disease processes. Yet the genotype alone is insufficient. It is the interaction between genotype and environment, expressed through the phenotype, that ultimately determines clinical outcomes. Imaging is thus indispensable in translating genetic information into clinically meaningful insights. The third pillar—AI, serves as the integrative force. The volume and complexity of data generated by modern imaging and genomic technologies exceed the capacity of traditional analytical methods. AI, particularly machine learning and deep learning, enables the identification of patterns, the generation of predictions, and the uncovering of relationships that would otherwise remain hidden. AI may not merely be a tool for automation; it is a tool for discovery. When applied thoughtfully, it can reveal new disease phenotypes, refine classifications, and guide personalized therapies.
However, the promise of this triad—phenotyping, genotyping, and intelligence—can only be realized through multidisciplinary collaboration. The era in which radiology operated as a relatively isolated specialty is rapidly fading. Today, meaningful progress requires the convergence of radiologists, clinicians, geneticists, data scientists, engineers, and bioinformaticians. Each brings a distinct perspective, and it is at their intersection that innovation occurs. This “golden age” of imaging is therefore not defined solely by technological advancement, but by the breaking down of traditional silos. The radiologist must understand genomics; the geneticist must appreciate imaging phenotypes; the data scientist must grasp clinical context. Without such integration, we risk generating data without insight, complexity without clarity.
It is within this context that Radiology-X assumes its significance. A journal is not merely a repository of manuscripts; it is a curator of direction. It does not simply reflect the field—it shapes it. The responsibility of a journal, particularly in its formative years, is profound. It must decide not only what is worthy of publication, but what is worthy of attention, of debate, and of pursuit.
There is a natural temptation in scientific publishing to equate value with volume, or impact with citation metrics. Journals may fall into the pattern of publishing what is readily available, favoring incremental advances over transformative ideas, or prioritizing popular topics in pursuit of higher impact factors. Others may align themselves too closely with a particular theme or methodology, thereby limiting the diversity of thought and innovation. Such approaches, while understandable, are insufficient for a journal that seeks to lead rather than follow.
The true value of Radiology-X will lie in its ability to anticipate where the field must go, and to select and promote work that moves it in that direction. This requires discernment, courage, and vision. It requires the willingness to publish work that challenges established paradigms, that bridges disciplines, and that may not yet have widespread recognition but holds the potential to redefine practice.
The journal must resist the passive model of “publishing as manuscripts come”. Instead, it must adopt an active role—identifying emerging areas of importance, encouraging submissions in those domains, and fostering dialogue that advances understanding. It must not merely reflect consensus but also create space for constructive dissent and exploration. Equally important is the need to balance rigor with openness. In an era of rapid innovation, particularly in AI, there is a risk of both overenthusiasm and undue skepticism. The journal must uphold the highest standards of scientific integrity while remaining receptive to novel approaches. It must distinguish between genuine advancement and superficial novelty, between robust methodology and overfitted models, between reproducible science and isolated findings.
One of the defining challenges of modern imaging research is reproducibility and generalizability. As datasets grow larger and models become more complex, ensuring that findings are robust across populations, institutions, and technologies becomes increasingly critical. Radiology-X has an opportunity to set standards in this regard by prioritizing studies that emphasize transparency, validation, and clinical relevance. Another essential responsibility is to promote integration. The future of imaging does not lie in isolation, but in its ability to connect with other domains. Studies that link imaging phenotypes with genomic data, that incorporate AI in clinically meaningful ways, or that demonstrate the impact of imaging on patient outcomes should be at the forefront. The journal can serve as a platform where these intersections are not only presented but critically examined. Furthermore, Radiology-X can play a pivotal role in education and thought leadership. Beyond original research, it can publish perspectives, reviews, and consensus statements that help define emerging fields. It can bring together experts from diverse disciplines to articulate shared goals and identify unmet needs. In doing so, it can guide not only researchers but also clinicians, policymakers, and trainees.
The importance of such guidance cannot be overstated. We are entering an era in which the pace of technological change can outpace our ability to assimilate it into clinical practice. Without thoughtful curation and interpretation, there is a risk that innovation becomes fragmented, that promising advances fail to translate into practice, and that the potential benefits to patients are not fully realized. At its core, medicine remains a human endeavor. The goal of all scientific progress is to improve the lives of patients—to diagnose earlier, to treat more effectively, and to do so with greater precision and compassion. Imaging, genomics, and AI are tools toward that end. Their value lies not in their sophistication but in their ability to enhance care.
In this regard, imaging holds a special place. It is often the first window into disease, the means by which uncertainty is reduced, and the basis for decision-making. It influences not only diagnosis but also prognosis, treatment planning, and monitoring. As imaging becomes more quantitative and integrated with other data sources, its role will only expand. Yet, with this expansion comes responsibility. Radiologists and imaging scientists must ensure that their work remains clinically grounded, that technological advances translate into meaningful improvements, and that the human element of care is preserved. AI, for example, should augment rather than replace clinical judgment. It should enhance efficiency while maintaining accountability.
Radiology-X can help navigate these complexities by fostering a culture of thoughtful innovation—one that embraces progress while maintaining perspective. It can encourage work that not only demonstrates technical excellence but also addresses clinical relevance, ethical considerations, and real-world applicability.
The journal’s commitment to multidisciplinary collaboration is particularly timely. The challenges we face—whether in understanding complex diseases, integrating diverse data sources, or implementing AI in clinical workflows—cannot be addressed by any single discipline. They require collective effort, shared language, and mutual respect. By serving as a platform for such collaboration, Radiology-X can catalyze new partnerships and ideas. It can bring together voices that might not otherwise intersect, creating opportunities for cross-pollination and innovation. It can highlight the importance of team science, where the whole is greater than the sum of its parts.
As we stand at this inflection point, it is worth reflecting on how far imaging has come—and how far it can go. From the early days of X-rays to the sophistication of modern multimodal imaging, the field has continually reinvented itself. Each advance has expanded our ability to see, to measure, and to understand. The next phase of this evolution will be defined not only by new technologies but by integration and interpretation. Imaging will be combined with genomics, clinical data, and environmental factors to create a more complete picture of health and disease. AI will help synthesize these inputs, generating insights that guide personalized care. In this future, the boundaries between disciplines will blur, and the role of imaging will become even more central. It will serve as both a foundation and a bridge—linking biology to clinical practice, data to decision-making, and innovation to impact.
The success of Radiology-X will depend on its ability to recognize and nurture this transformation. It must be bold in its vision, rigorous in its standards, and inclusive in its scope. It must be willing to take risks, to challenge conventions, and to champion ideas that have the potential to redefine the field. Above all, it must remain committed to its ultimate purpose: advancing medicine in ways that benefit patients and society.
The inaugural issue marks the beginning of this journey. It is an opportunity to set the tone, to articulate the journal’s values, and to signal its aspirations. It is also an invitation—to researchers, clinicians, and thinkers—to contribute to a shared endeavor. The path ahead will not be without challenges. The integration of imaging, genomics, and AI raises questions about data privacy, equity, and access. It requires new frameworks for validation, regulation, and implementation. It demands ongoing dialogue and reflection. But it is precisely in addressing these challenges that the field will grow. And it is through platforms like Radiology-X that such growth can be guided and sustained.
The emergence of Radiology-X is both timely and necessary. It arrives at a moment when imaging is poised to play a defining role in the future of medicine, when multidisciplinary collaboration is no longer optional but essential, and when thoughtful leadership in scientific publishing is urgently needed. It has another responsibility. It must bring to the fore the burgeoning scientific discoveries in China. It must attract what is new beyond Chinese borders and provide fertile ground for inviting collaboration. It will be a face of Sino-imaging but a melting pot for imaging research.
May this journal not only document progress but shape it. May it not only disseminate knowledge but also inspire it. And may it serve as a beacon for where the field must move—grounded in rigor, guided by vision, and dedicated to the advancement of human health. Best wishes to Neng Dai and his editorial team.
Acknowledgments
None.
Footnote
Provenance and Peer Review: This article was commissioned by the editorial office, Radiology-X. The article did not undergo external peer review.
Funding: None.
Conflicts of Interest: The author has completed the ICMJE uniform disclosure form (available at https://rx.amegroups.com/article/view/10.21037/rx-2026-2-6/coif). J.N. serves as an unpaid advisory board member of Radiology-X from February 2026 to January 2028. The author has no other conflicts of interest to declare.
Ethical Statement:
Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
Cite this article as: Narula J. Phenotype, genotype, intelligence & Radiology-X. Radiology-X 2026;1:2.